A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The objective of this study was to evaluate the effectiveness of lamotrigine in reducing affective instability in borderline personality disorder (BPD). We conducted a 12-week, double-blind, placebo-controlled study of 28 patients who met Revised Diagnostic Interview for Borderlines and Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for BPD. Patients could not meet Diagnostic and Statistical Manual of Mental Disorders, fourth edition criteria for bipolar disorder. Patients could be taking one antidepressant during the study. Patients were randomly assigned to treatment with flexible-dose lamotrigine or placebo in a 1 : 1 manner. The primary outcome measures were: (i) the Affective Lability Scale total score; and (ii) the Affective Instability Item of the Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD). The study randomized 15 patients to receive lamotrigine and 13 patients to receive placebo. Patients in the lamotrigine group had significantly greater reductions in the total Affective Lability Scale scores (P<0.05) and significantly greater reductions in scores on the affective instability item of the ZAN-BPD (P<0.05). A secondary finding was that patients in the lamotrigine group had significantly greater reductions in scores on the ZAN-BPD impulsivity item (P = 0.001). Results from the study suggest that lamotrigine is an effective treatment for affective instability and for the general impulsivity characteristic of BPD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Revised Diagnostic Interview for Borderlines: Discriminating BPD from other Axis II Disorders
Zanarini, M. C., Gunderson, J. G., Frankenburg, F. R., & Chauncey, D. L. (1989) · Journal of Personality Disorders · doi:10.1521/pedi.1989.3.1.10 · Cited by 596 · cited 3×
“We evaluated patients using the Structured Clinical Interview for Axis I Disorders, the DIB-R, the ALS, and the ZAN-BPD.”
MethodSelf-citationZanarini, M. C. (2003) · Journal of Personality Disorders · doi:10.1521/pedi.17.3.233.22147 · Cited by 413
Self-citationFrankenburg, F. R., & Zanarini, M. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0511 · Cited by 221
Self-citationBorderline personality disorder in patients with bipolar disorder and response to lamotrigine
Preston, G. A., Marchant, B. K., Reimherr, F. W., Strong, R. E., & Hedges, D. W. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00358-0 · Cited by 82
Cited by
Borderline personality disorder
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61422-5 · Cited by 895
Pharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
“More recently, BPD patients without comorbid bipolar disorder but with prominent affective instability demonstrated reduced affective lability and impulsivity, but no change in other BPD symptoms, when treated with lamotrigine (Reich et al. 2009).”
BackgroundMethodInfluential
Metadata
- Authors
- Reich, D. B., Zanarini, M. C., & Bieri, K. A.
- Venue
- International Clinical Psychopharmacology
- Published
- 2009-07
- Volume
- 24
- Issue
- 5
- Pages
- 1
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2055166757
- Cited by
- 77
- References
- 4
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. https://app.cochat.ai/papers/10.1097/yic.0b013e32832d6c2f
- The paper
- Reich, D. B., Zanarini, M. C., & Bieri, K. A. (2009). A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0b013e32832d6c2f
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.